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Recent work has demonstrated the enhancement of 
hormone-stimulated inositol trisphosphate formation in 
renal epithelial cells under conditions of glucosylcer- 
amide depletion. The role of glucosylceramide metabo- 
lism was explored further by exposing Madin-Darby ca- 
nine kidney (MDCK) cells to the fi-glucosidase inhibitor 
conduritol B epoxide, which produced time-dependent 
and concentration-dependent increases in glucosylcer- 
amide levels and decreased bradykinin-stimulated ino- 
sitol trisphosphate formation from isolated MDCK cell 
membranes. These data provide further support for an 
association between glucosylceramide levels and hor- 
mone-stimulated inositol trisphosphate formation. o issz 
Academic Press, Inc. 
Glycosphingolipids are membrane components that are 
composed of a long chain sphingoid amine (a sphingol), 
a fatty acid, and a carbohydrate. The hydrophobic moiety, 
ceramide, consists of the sphingol substituted at the amino 
group by a fatty acid in amide linkage. The carbohydrate 
moiety is linked at the primary hydroxyl group of the 
sphingol in a glycosidic linkage. GlcCer is the most widely 
distributed glycolipid; it serves as the base for over 200 
known glucosphingolipids. It is formed by ceramide:UDP- 
glucose glucosyltransferase, which can be inhibited by the 
GlcCer analogue D-threo-PDMP3 (l-4). GlcCer is de- 
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graded by a &glucosidase that is inhibitable by CBE (5, 
6). Recently we reported that depletion of GlcCer by ex- 
posure of MDCK cells to PDMP resulted in a significant 
potentiation of hormone-stimulated InsP3 formation in 
both intact MDCK cells and isolated plasma membrane 
of these cells (4). This effect was reversed by exposure of 
cells to exogenously added GlcCer. We now report that 
an increase in endogenous GlcCer in MDCK cells results 
in a significant decrease in hormone-stimulated InsP3 
formation. This observation provides further support for 
the hypothesis that GlcCer or a GlcCer metabolite mod- 
ulates the hydrolysis of phosphatidylinositol bisphos- 
phate. 
MATERIALS AND METHODS 
Materials. PDMP and CBE were synthesized as previously described 
(7,B). [6-3H]Galactose (30 Ci/mmol), [9,10(n)-3H]palmitat (52 Ci/mol), 
and myo-[2-3H]inositol 1,4,5-trisphosphate (45 Ci/mmol) were from 
Amersham (Arlington Heights, IL). Glucosylceramide was isolated from 
the spleen of a patient with Gaucher disease (9). Galactosylceramide 
from bovine brain was from Serdary (Port Huron, MI). MDCK cells 
were from the American Type Culture Collection (CCL-34, Rockville, 
MD). Bradykinin was from Sigma Chemical Co. (St. Louis, MO), gua- 
nosine-5’-0-(3-thiotriphosphate) (GTPyS) was from Boehringer 
Mannheim Biochemicals (Indianapolis, IN), and ganglioside standards 
were from Matreya, Inc. (Pleasant Gap, PA). 
Glycosphingo&id extraction and isolation. MDCK cells (5 X 105) 
were grown in 57-cm* flasks in defined (serum-free) medium according 
to the formulation of Taub (10). [3H]Galactose (5 &i/ml) or 
[3H]palmitate (5 @i/ml) with or without 20 PM PDMP was added 24 
h after plating. The radiolabeled compounds were added to the medium 
prior to filtering. Medium containing [3H]palmitate was sonicated for 
10 min prior to filtration. After another 24 h, the cells were scraped off 
the flask with a rubber policeman and extracted three times with 3 ml 
2-decanoylamino-3-morpholino-1-propanol; MDCK, Madin-Darby ca- 
nine kidney; EGTA, ethylene glycol bis(P-aminoethyl ether)N,N’-tet- 
raacetic acid. 
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of C:M (1:2). The pooled extracts from a single flask were evaporated 
to dryness. The residues were suspended in 1 ml of C:M:W (3060~8) 
and applied to a DEAE-Sepha’dex column (0.44 g in 10 X l-cm column, 
AcO- form, equilibrated with C:M:W (30:60:8). Neutral lipids were eluted 
with 30 ml of the same solvent and acidic lipids were eluted with 30 ml 
of C:M:0.3 M sodium acetate (30~60:s). The eluates were evaporated 
under nitrogen and subjected to alkaline methanolysis, by adding 3 ml 
of 0.5 N NaOH in methanol and heating for 60 min at 4O’C. The samples 
were dialyzed against tap water at 4°C for 24 h and dried in uacuo. The 
neutral lipid fraction was then suspended in 1 ml of C:M (982) and 
subjected to silicic acid chromatography with 0.5 g of Unisil (200-325 
mesh, Clarkson Chemical, Williamsport, PA). Ceramides were eluted 
with 35 ml of C:M (98:2), cerebrosides were eluted with 35 ml of C:M 
(80:20), and sphingomyelin was eluted with 35 ml of C:M:W (50:50:5). 
The acidic lipid fraction from the DEAE-Sephadex column was also 
subjected to alkaline methanolysis and dialysis. 
Thin layer chromatography. Samples were analyzed by high-perfor- 
mance thin layer chromatography (10 X 10 cm HPTLC plates from E. 
Merck, Darmstadt). Galactosyl- and glucosylceramides were separated 
with C:M:W (65:25:4) on plates which had been developed with 2.5% 
borax in M:W (1:l) and heated at 110°C prior to use. The acidic gly- 
cosphingolipids were separated with C:M:0.2% CaCl, (60:40:9). Ceramide 
(isolated from [3H]palmitate-laheled cells) was developed with hexane: 
C (1:l) followed by C:M:HOAc (91:2:3). Sphingomyelin was separated 
in a solvent system utilizing C:M:W (60:35:8). Plates were exposed for 
96 h to Kodak X-OMAT AR film following treatment with En3Hance 
spray. Charring was done with other plates using GlcCer standards and 
the copper sulfate-phosphoric acid reagent (11). Cerebrosides were 
quantitated by densitometry using a Bio-Rad 620 videodensitometer 
and 2-D Analyst software. 
Plasma membranepreparation. Crude plasma membranes were iso- 
lated following exposure to hypotonic buffer by the protocol of Hepler 
and Harden (12). Prior to the exposure to agonist, the membranes were 
pelleted at 12,000g. Protein was determined utilizing the fluorescamine 
reagent (13). 
Inositol 1,4,5-trisphosphate determination. Hormone-stimulated 
InsP3 formation was measured1 in intact MDCK cells as previously de- 
tailed (4, 14). For broken cell studies, membranes were suspended in 
100 ~1 of a buffer consisting of 10 mM Hepes, 2 mM EGTA, 424 pM 
CaCl,, 0.91 mM MgSO,, 115 mM KCl, and 5 mM KH*PO,, pH 7.0. 
Additions consisting of the same buffer, containing 50 ~1 of 3.0 pM 
GTPyS and 0.3 FM bradykinin, were made. After 15 s, 150 ~1 of 6% 
trichloroacetic acid was added and the resultant precipitate was sedi- 
mented by centrifugation at 5000g. The supernatant was treated with 
trioctylamine-Freon to extract the acid. InsP3 formation was measured 
by a competitive binding assay utilizing high specific activity myo-[2- 
3H]inositol 1,4,5trisphosphate binding to calf adrenocortical microsomes 
(15) as recently applied for measurements in intact MDCK cells (4, 14). 
Exogenous cerebroside incorporation. GlcCer, labeled with [3H] 
palmitate, was prepared as previously described (16) and studied as fol- 
lows. Dioleoylphosphatidylcholine (12.8 mg), GlcCer (1.5 mg), and 
[3H]GlcCer (2.71 X lo6 cpm) in C:M (2:l) were dried under nitrogen 
and suspended in 1.5 ml of phosphate-buffered saline. The mixture was 
vortexed and sonicated for 20 m in using a probe sonicator. The dispersion 
was centrifuged for 10 min at 1500 rpm and the supernatant was filtered 
through a 0.2-bcm filter. 
MDCK cells were plated on a loo-mm dish and 209 ~1 of the liposomal 
preparation was added to 8 ml of medium. After 24 h the medium was 
aspirated and the cells were washed with phosphate-buffered saline. 
Cellular lipids from each dish ‘were extracted with 2 ml of hexane:iso- 
propanol (3:2). The extract was dried under nitrogen and dissolved in 
200 ~1 of C:M (2:l). Thirteen microliters of 0.3 M taurocholate was added 
to 50 ~1 of this extract. The solution was dried and subjected to cy- 
galactosidase treatment (coffee bean Lu-galactosidase, Sigma). Another 
50 11 was dried, suspended in 300 ~1 CHC13, and subjected to alkaline 
methanolysis (150 ~1 of 0.21 N NaOH in MeOH) for 60 min. Methanolysis 
was stopped with the addition of 110 ~1 of 0.34 M acetic acid. The phases 
were separated by centrifugation and the lower phase was washed with 
an equal volume of M:W (1:l). The lower phase was dried and dissolved 
in C:M (2:l) prior to spotting on TLC. 
For studies not utilizing radiolabeled cerebroside, liposomes containing 
dioleoylphosphatidylcholine were prepared in the same manner. The 
amount of GlcCer added, however, was varied with a constant amount 
of phosphatidylcholine to yield a final concentration as indicated under 
Results. 
RESULTS 
The comparative effects of 20 PM CBE and of the 
GlcCer synthase inhibitor, D-threo-PDMP, on GlcCer 
content are displayed in Fig. 1. Exposure of MDCK cells 
to the GlcCer synthase and P-glucosidase inhibitors re- 
sulted in a time-dependent decrease or increase in GlcCer 
content, respectively. 
The time- and concentration-dependent effects of CBE 
exposure on GlcCer content (Fig. 2) were assayed by 
charring and videodensitometry. The GlcCer content of 
untreated cells, normalized for cell protein, reproducibly 
increased as a function of cell density even in the absence 
of inhibitor. Upon exposure to CBE, GlcCer content was 
greater at 48 h compared to 24 h at all concentrations of 
the glucosidase inhibitor. 
Table I displays the sphingolipid profile of MDCK cells 
exposed to 20 PM CBE for 48 h as determined by 
[3H]galactose labeling for the cerebrosides and ganglioside 
GM3 or [3H]palmitate for labeling for ceramide and 
sphingomyelin. The activity of GlcCer in the presence of 
inhibitor was more than twice that of control cells, show- 
ing that GlcCer undergoes metabolic turnover in these 
cells. Galactosylceramide and ganglioside GM3 labeling 
was unchanged. Small but consistent increases in sphin- 
gomyelin and ceramide labeling were consistently ob- 
served. 
As previously reported, GlcCer synthase inhibition re- 
sulted in a significant increase in bradykinin-stimulated 
InsP3 formation from isolated MDCK cell membranes 
GlcCet- c ,_ 
GalCer- 
I 
con-24 P-24 COW48 P-48 STDS Con-24 CBE-24 Con-48 CEIE-48 
FIG. 1. Comparative effects of GlcCer synthase and P-glucosidase 
inhibition on GlcCer content of MDCK cells. Cells were grown for 24 
or 48 h in the presence of either 20 PM D-threo PDMP or CBE. After 
the indicated incubation periods, the cerebrosides were extracted and 
separated on borate-impregnated plates as described under Materials 
and Methods. Samples were detected by charring and compared to au- 
thentic standards. The chromatogram represents one of three indepen- 
dent experiments. The dark band migrating between GlcCer and GalCer 
represents dialkyl species of phosphatidylethanolamine. 
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FIG. 2. Concentration-dependent changes in GlcCer content of 
MDCK cells following exposure to CBE. Cells were incubated for either 
24 h (0) or 48 h (0) in the presence of various concentrations of the p- 
glucosidase inhibitor. The cerebroside was quantitated by charring and 
densitometric detection in comparison to known weights of authentic 
GlcCer. Measurements were made in triplicate. The CBE data were 
significantly different from the control data at all concentrations of 
CBE. 
(4). Conduritol B epoxide produced the opposite effect. 
The change in InsP3 formation as a function of the du- 
ration of CBE exposure is shown in Fig. 3. The slight 
decrement in InsP3 formation evident at 24 h is further 
enhanced by 48 h of exposure to the glucosidase inhibitor. 
This time-dependent effect occurred at a slower rate when 
compared to that of the GlcCer synthase inhibitor, 
PDMP, and probably reflects a slower rate of GlcCer deg- 
radation as compared to GlcCer synthesis in these growing 
cells. In addition, control cells displayed a time-dependent 
decrease in stimulated InsP3 formation (Fig. 3). This de- 
crease paralleled the increase in cell-associated GlcCer 
under control conditions when normalized for cellular 
protein. A concentration-dependent effect of CBE on 
InsP3 formation was also observed (Fig. 4). This effect 
was maximal at 20 PM CBE. The effect on InsP3 levels 
TABLE I 
Radiolabeling of Sphingolipids in Control 
and CBE-Exposed MDCK Cells” 
Lipid counted 
Control cells CBE cells 
(cpm/pg protein) (cpm/ag protein) 
Glucosylceramide 2.79 k 0.35 6.58 f 1.98* 
Galactosylceramide 0.74 + 0.11 0.97 t 0.26 
Ganglioside GM3 6.04 f 0.28 6.04 f 1.28 
Ceramide 25.5 f 0.76 31.4 zk 0.56* 
Sphingomyelin 175 f 4.5 214 +- 9.1 
’ Sphingolipid labeling was performed as described under Materials 
and Methods. Data represent the mean & SE of four or five independent 
determinations. 
* P < 0.02 by the paired t test. 
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FIG. 3. InsP3 formation from MDCK cell membranes of cells exposed 
to CBE. MDCK cells were grown in the presence (0) or absence (0) of 
20 pM CBE for 0, 24, or 48 h. Cell membranes were isolated and InsP3 
formation in response to 10m7 M bradykinin and 1 pM GTPyS was de- 
termined as described under Materials and Methods. The error bars 
represent 1 SD from the mean of triplicate values. 
was not the result of increased substrate levels. No dif- 
ference in phosphatidylinositol bisphosphate was seen in 
MDCK cells treated with 20 PM CBE when compared to 
untreated control cells (1.34 + 0.23 versus 1.25 + 0.17 
nmol/mg protein). 
The change in InsP3 levels associated with changes in 
cerebroside content may be the result of impaired for- 
mation or catabolism. The 5-phosphomonoesterase that 
degrades InsP3 is magnesium dependent and inhibitable 
by a variety of glycolytic intermediates including 2,3-bis- 
phosphoglycerate (17). Although no 3-kinase activity was 
observed in the isolated membrane preparations, a small 
amount of 5-phosphatase activity was observed, as evi- 
denced by the formation of inositol 1,4-bisphosphate. 5- 
1201 
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FIG. 4. Concentration-dependent effect of CBE on InsP3 formation 
by plasma membranes. MDCK cells were incubated for 24 h with varying 
concentrations of CBE. Membranes were isolated and hormone-stim- 
ulated InsP3 formation was determined as described in the legend to 
Fig. 3. 
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FIG. 5. InsP3 formation in the absence (A) or presence (B) of 5-phosphomonoesterase inhibition with 2,3-bisphosphoglycerate. MDCK cells 
were grown in the presence or absence of inhibitors and membranes were isolated as described under Materials and Methods. InsP3 formation 
in response to bradykinin and GTPyS was determined following a 15-s incubation. 
Phosphomonoesterase activity was effectively eliminated 
by the use of a magnesiu.m-free buffer containing 10 mM 
Hepes, 2 mM EGTA, 424 PM CaC&, 115 mM KCl, and 5 
mM KH2P04, pH 7.0, and 2 mM 2,3-bisphosphoglycerate. 
The comparative levels of InsP3 from membranes incu- 
bated with magnesium-containing buffer and magnesium- 
free buffer with 2,3-bisphosphoglycerate are shown in Fig. 
5. A three- to fivefold potentiation in InsP3 formation 
was observed under the latter conditions; however, the 
effects of altered cerebroside content persisted. 
The ability of exogenously added GlcCer to modulate 
InsP3 formation was stuldied by exposing MDCK cells to 
GlcCer in liposomes containing phosphatidylcholine. In- 
corporation of GlcCer was established by the addition of 
GlcCer radiolabeled with [3H]palmitate (Fig. 6). Several 
products were labeled 24. h following the addition of the 
tritiated cerebroside. Most of the labeled products ap- 
peared to be the result of hydrolysis of the labeled cere- 
broside with incorporation of label into phosphatidylcho- 
line and nonpolar lipidls, probably cholesterol esters. 
Alkaline methanolysis confirmed the incorporation of a 
significant amount of label into phosphatidylcholine. 
The effect of exogenously added cerebroside on InsP3 
formation was assessed (Fig. 7). CBE, which resulted in 
GlcCer accumulation, significantly lowered the rate of 
InsP3 formation. GlcCer <alone decreased InsP3 formation 
slightly but significantly but, when added in combination 
with CBE, its effectivenless was potentiated by the glu- 
cosidase inhibitor. This effect was not observed with ga- 
lactosylceramide. 
The concentration dependence of exogenously added 
GlcCer was also determined (Fig. 8). GlcCer potentiated 
the inhibitory effects of CBE on InsP3 formation. The 
addition of 25 pg/ml of the cerebroside in the presence of 
CBE almost totally inhibited the formation of InsP3. Ex- 
posure of cells to phosphatidylcholine-containing lipo- 
somes alone was without effect. 
DISCUSSION 
Glycosphingolipids have been implicated as modulators 
of a variety of important cellular processes including 
growth (18), differentiation (19), and ionic transport (20). 
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FIG. 6. The incorporation and metabolism of [3H]GlcCer in MDCK 
cells. Liposomes containing radiolabeled cerebroside were added to the 
incubation media. Following 24 h the cells were washed with phosphate- 
buffered saline. Cell lipids were extracted and separated by TLC following 
no treatment (Con) or following alkaline methanolysis (AM). TLC sep- 
aration utilized CHCl,:MeOH:water 60:35:8 on a borax treated plate. 
Products were identified by fluororadiography. Phosphatidylcholine 
(PC), sphingomyelin (SM), lactosylceramide (LacCer), standard (Std). 
510 MAHDIYOUN ET AL. 
1 
FIG. ‘7. Effects of exogenous cerebrosides on InsP3 formation. MDCK 
cells were grown in the presence of GlcCer- or galactosylceramide-con- 
taining liposomes with or without CBE. Cell membranes were isolated 
and InsP3 formation was determined as described above. 
the modulation of signal transduction. This has been most 
extensively investigated with regard to tyrosine kinase 
activity (2, 21). However, the activities of other cellular 
kinases including protein kinase C (22, 23) and calcium- 
calmodulin kinases (24) have been shown to be affected 
by exogenous addition of gangliosides. The activities of 
all three kinases have been demonstrated to modulate 
either InsP3 formation or catabolism. Recently, we re- 
ported a modulatory role for glucosphingolipids in the 
formation of bradykinin-stimulated inositol trisphosphate 
(4). Depletion of GlcCer with the synthase inhibitor 
PDMP resulted in time- and concentration-dependent 
increases in inositol trisphosphate formation. In the 
present study we extended these observations to include 
conditions of GlcCer excess. 
The GlcCer content of MDCK cells was shown to in- 
crease in the presence of the P-glucosidase inhibitor CBE. 
A corresponding impairment of hormone-stimulated ino- 
sitol trisphosphate formation was observed. This inhi- 
bition paralleled the concentration of CBE utilized as well 
as the duration of exposure of MDCK cells to the inhib- 
itor. The incorporation of exogenously added GlcCer into 
MDCK cells was documented with the use of tritiated 
cerebroside radiolabeled in the fatty acid moiety. Although 
significant catabolism was evident, an impairment of ino- 
sitol trisphosphate formation was still observed under 
these conditions. 
In interpreting data based on the use of inhibitors, it 
is important to consider the possibility that the observed 
changes are the result of other, unknown effects of these 
agents. In the case of CBE, several studies have found 
inhibition of ,#-glucosidase to be the only major effect 
(25-27). 
These data are consistent with a role for GlcCer or of 
a related metabolite in mediating the formation of hor- 
mone-stimulated inositol trisphosphate. This conclusion 
is supported by the complementary nature of the gluco- 
sidase inhibitor on GlcCer levels and InsP3 formation 
when compared to the previous study evaluating GlcCer- 
depleted cells. Two questions arise from these observa- 
tions. First, are the effects of altering GlcCer content on 
InsP3 formation the result of GlcCer alone or is the effect 
the result of changes in a related metabolite? Second, 
what is the mechanism responsible for the observed effects 
on InsP3 formation? 
Regarding the first question, it is likely that GlcCer or 
a metabolite and not an anabolite mediates the effects on 
InsP3 formation. Although P-glucosidase and GlcCer 
synthase inhibition display opposite effects on InsP3 for- 
mation, they did not have complementary effects on gan- 
glioside content (Table I). PDMP significantly lowered 
ganglioside GM3 labeling (4); CBE displayed no effects 
on GM3 even with prolonged incubation. Similarly, the 
observed increases in ceramide and sphingomyelin label- 
ing were independent of the changes in GlcCer levels, 
suggesting that sphingomyelin or ceramide metabolism 
alone would be insufficient to account for the observed 
changes in InsP3 formation. The increased labeling of 
sphingomyelin and ceramide due to CBE and GlcCer ac- 
cumulation may be the result of activation of protein ki- 
nase C. 
Both ganglioside GM3 (28) and sphingomyelin (29,30) 
have been implicated in signaling and differentiation 
events. In addition, exposure to exogenous GlcCer resulted 
in a significant inhibition of InsP3 formation. However, 
in the absence of CBE, very little [3H]GlcCer could be 




FIG. 8. Concentration dependence of exogenously added GlcCer on 
InsP3 formation. GlcCer-containing liposomes were prepared as de- 
scribed under Materials and Methods. All cells except for control cells 
were incubated with 20 pM CBE and liposomes for 24 h. Control cells 
were incubated with dioleoylphosphatidylcholine alone. The numbers 
refer to the GlcCer concentration in pg/ml of medium. 
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or to acidic glycosphingolipids due to the high degree of 
hydrolysis. 
Regarding the second question, several potential 
mechanisms could explain the effect of GlcCer on InsP3 
formation. These include the reported effects of glyco- 
sphingolipids on tyrosine kinase, protein kinase C, or 
CAMP formation, with secondary effects on phospholipase 
C activity. Recent studies in MDCK cells have revealed 
that PDMP and CBE treatment are associated with in- 
hibition and stimulation ‘of protein kinase C activity, re- 
spectively (31). Altered protein kinase C activity may not 
only explain the mechanism for cerebroside-associated 
changes in phospholipase C, but could also explain the 
observed increase in cera.mide and sphingomyelin label- 
ing (32). 
The ability to modulate endogenous glucosphingolipid 
content should provide art important tool for defining the 
role of glycosphingolipids in cellular signaling events. 
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